Bio’s compound significantly reduces age-related random RNA processing errors, thus eliminating multiple faulty RNAs and resulting toxic proteins with one compound.

Its utility spans across multiple therapeutic categories, including age-related neurodegenerative diseases and cancer, areas of high unmet medical need, and significant commercial potential.

As the global population ages, age-related diseases have become a significant, growing concern and socioeconomic burden, currently inadequately addressed by existing therapies.

Our therapy holds the potential to address the root cause of many of these age-related dysfunctional proteins and the diseases they cause.